반려동물용 PoC 혈액검사 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 검사 카테고리별, 동물별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)

Companion Animal PoC Blood Testing Market Summary

The global companion animal point of care blood testing market size was valued at USD 1.0 billion in 2025 and is projected to grow from USD 1.1 billion in 2026 to USD 2.2 billion by 2033, at a CAGR of 9.5% from 2026 to 2033. The North America market held the largest revenue share of 38.9% in 2025. The market is driven by rising companion animal ownership, increasing pet healthcare expenditure, and growing demand for rapid, accurate point of care diagnostics.

In addition, the expanding prevalence of chronic, infectious, endocrine, renal, and metabolic diseases is accelerating routine blood testing. Other factors contributing to the market include the adoption of preventive healthcare, expanding veterinary clinic networks, faster treatment initiation, increasing awareness of early disease detection, and continuous product innovation by leading diagnostic companies, which are further strengthening global market growth.

Global Companion Animal PoC Blood Testing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global companion animal PoC blood testing market report based on product, testing category, animal, end use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Instruments
  • Biochemistry Analyzers
  • Immunoassay Analyzers
• Consumables & Reagents
  • Biochemistry Analyzers
  • Immunoassay Analyzers
• Testing Category Outlook (Revenue, USD Million, 2021 - 2033)
• Clinical Chemistry/Biochemistry Testing
  • Liver Function Testing
  • Kidney Function Testing
  • Electrolyte Testing
  • Metabolic Panels
• Immunoassay Testing
  • Infectious Disease Immunoassays
  • Non-Infectious Immunoassays
  • Thyroid Hormone Testing
  • Cardiac Marker Testing
  • Endocrine Biomarker Testing
  • Inflammatory Marker Testing
• Animal Outlook (Revenue, USD Million, 2021 - 2033)
• Dogs
• Cats
• Horses
• Other Companion Animals
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Veterinary Hospitals & Clinics
• Reference Laboratories
• Academic & Research Institutes
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Norway
  • Sweden
  • Denmark
• Asia Pacific
  • Japan
  • India
  • China
  • South Korea
  • Thailand
  • Australia
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Oman
  • Qatar

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Testing Category
  • 1.2.3. Animal
  • 1.2.4. End Use
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information/Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Model 1: Commodity Flow Analysis
  • 1.7.2. Model 2: Bottom-Up Analysis
  • 1.7.3. Model 3 Multivariate Analysis
• 1.8. List of Secondary Sources
• 1.9. List of Abbreviations
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Market Variable Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Growing Demand for Same-Day Blood Testing Services in Veterinary Clinics
    • 3.2.1.2. Rising Utilization of Preventive and Wellness Blood Testing Packages
    • 3.2.1.3. Growing Burden of Chronic and Age-Related Conditions in Companion Animals
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High Instrument Cost and Recurring Consumable Burden for Small Veterinary Clinics
    • 3.2.2.2. Operational, Accuracy, and Quality-Control Challenges in Clinic-Based Testing
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenge Analysis
• 3.3. Companion Animal Ownership Trend
• 3.4. Technology Landscape
• 3.5. Pricing Analysis
• 3.6. Estimated Animal Population, by Key Species & Key Countries, 2021-2025
• 3.7. Market Analysis Tools
  • 3.7.1. Porter's Five Forces Analysis
  • 3.7.2. PESTEL Analysis

Chapter 4. Companion Animal PoC Blood Testing Market: Product Estimates & Trend Analysis

• 4.1. Companion Animal PoC Blood Testing Market by Product, Segment Dashboard
• 4.2. Companion Animal PoC Blood Testing Market: Product Movement Analysis
• 4.3. Companion Animal PoC Blood Testing Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 4.4. Instruments
  • 4.4.1. Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.2. Biochemistry Analyzers
    • 4.4.2.1. Biochemistry Analyzers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.3. Immunoassay Analyzers
    • 4.4.3.1. Immunoassay Analyzers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Consumables & Reagents
  • 4.5.1. Consumables & Reagents Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.2. Biochemistry Analyzers
    • 4.5.2.1. Biochemistry Analyzers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.3. Immunoassay Analyzers
    • 4.5.3.1. Immunoassay Analyzers Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Companion Animal PoC Blood Testing Market: Testing Category Estimates & Trend Analysis

• 5.1. Companion Animal PoC Blood Testing Market by Testing Category, Segment Dashboard
• 5.2. Companion Animal PoC Blood Testing Market: Testing Category Movement Analysis
• 5.3. Companion Animal PoC Blood Testing Market Size & Trend Analysis, by Testing Category, 2021 to 2033 (USD Million)
• 5.4. Clinical Chemistry/Biochemistry Testing
  • 5.4.1. Clinical Chemistry/Biochemistry Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4.2. Liver Function Testing
    • 5.4.2.1. Liver Function Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4.3. Kidney Function Testing
    • 5.4.3.1. Kidney Function Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4.4. Electrolyte Testing
    • 5.4.4.1. Electrolyte Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4.5. Metabolic Panels
    • 5.4.5.1. Metabolic Panels Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Immunoassay Testing
  • 5.5.1. Immunoassay Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5.2. Infectious Disease Immunoassays
    • 5.5.2.1. Infectious Disease Immunoassays Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5.3. Non-Infectious Immunoassays
    • 5.5.3.1. Non-Infectious Immunoassays Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.3.2. Thyroid Hormone Testing
      • 5.5.3.2.1. Thyroid Hormone Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.3.3. Cardiac Marker Testing
      • 5.5.3.3.1. Cardiac Marker Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.3.4. Endocrine Biomarker Testing
      • 5.5.3.4.1. Endocrine Biomarker Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.3.5. Inflammatory Marker Testing
      • 5.5.3.5.1. Inflammatory Marker Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Companion Animal PoC Blood Testing Market: Animal Estimates & Trend Analysis

• 6.1. Companion Animal PoC Blood Testing Market by Animal, Segment Dashboard
• 6.2. Companion Animal PoC Blood Testing Market: Animal Movement Analysis
• 6.3. Companion Animal PoC Blood Testing Market Size & Trend Analysis, by Animal, 2021 to 2033 (USD Million)
• 6.4. Dogs
  • 6.4.1. Dogs Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Cats
  • 6.5.1. Cats Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Horses
  • 6.6.1. Horses Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Other Companion Animals
  • 6.7.1. Other Companion Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Companion Animal PoC Blood Testing Market: End Use Estimates & Trend Analysis

• 7.1. Companion Animal PoC Blood Testing Market by End Use, Segment Dashboard
• 7.2. Companion Animal PoC Blood Testing Market: End Use Movement Analysis
• 7.3. Companion Animal PoC Blood Testing Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 7.4. Veterinary Hospitals & Clinics
  • 7.4.1. Veterinary Hospitals & Clinics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.5. Reference Laboratories
  • 7.5.1. Reference Laboratories Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Academic & Research Institutes
  • 7.6.1. Academic & Research Institutes Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Companion Animal PoC Blood Testing Market: Regional Estimates & Trend Analysis

• 8.1. Regional Dashboard
• 8.2. Companion Animal PoC Blood Testing Market Share, By Region, 2025 & 2033 (USD Million)
• 8.3. North America
  • 8.3.1. North America Companion Animal PoC Blood Testing Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.3.2. U.S.
    • 8.3.2.1. Key Country Dynamics
    • 8.3.2.2. Competitive Scenario
    • 8.3.2.3. Regulatory Framework
    • 8.3.2.4. U.S. Companion Animal PoC Blood Testing Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.3.3. Canada
    • 8.3.3.1. Key Country Dynamics
    • 8.3.3.2. Competitive Scenario
    • 8.3.3.3. Regulatory Framework
    • 8.3.3.4. Canada Companion Animal PoC Blood Testing Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.3.4. Mexico
    • 8.3.4.1. Key Country Dynamics
    • 8.3.4.2. Competitive Scenario
    • 8.3.4.3. Regulatory Framework
    • 8.3.4.4. Mexico Companion Animal PoC Blood Testing Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 8.4. Europe
  • 8.4.1. Europe Companion Animal PoC Blood Testing Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.4.2. UK
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Scenario
    • 8.4.2.3. Regulatory Framework
    • 8.4.2.4. UK Companion Animal PoC Blood Testing Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.4.3. Germany
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Scenario
    • 8.4.3.3. Regulatory Framework
    • 8.4.3.4. Germany Companion Animal PoC Blood Testing Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.4.4. France
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Scenario
    • 8.4.4.3. Regulatory Framework
    • 8.4.4.4. France Companion Animal PoC Blood Testing Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.4.5. Italy
    • 8.4.5.1. Key Country Dynamics
    • 8.4.5.2. Competitive Scenario
    • 8.4.5.3. Regulatory Framework
    • 8.4.5.4. Italy Companion Animal PoC Blood Testing Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.4.6. Spain
    • 8.4.6.1. Key Country Dynamics
    • 8.4.6.2. Competitive Scenario
    • 8.4.6.3. Regulatory Framework
    • 8.4.6.4. Spain Companion Animal PoC Blood Testing Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.4.7. Norway
    • 8.4.7.1. Key Country Dynamics
    • 8.4.7.2. Competitive Scenario
    • 8.4.7.3. Regulatory Framework
    • 8.4.7.4. Norway Companion Animal PoC Blood Testing Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.4.8. Denmark
    • 8.4.8.1. Key Country Dynamics
    • 8.4.8.2. Competitive Scenario
    • 8.4.8.3. Regulatory Framework
    • 8.4.8.4. Denmark Companion Animal PoC Blood Testing Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.4.9. Sweden
    • 8.4.9.1. Key Country Dynamics
    • 8.4.9.2. Competitive Scenario
    • 8.4.9.3. Regulatory Framework
    • 8.4.9.4. Sweden Companion Animal PoC Blood Testing Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Asia Pacific Companion Animal PoC Blood Testing Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.5.2. Japan
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. Japan Companion Animal PoC Blood Testing Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.5.3. China
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. China Companion Animal PoC Blood Testing Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.5.4. India
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. India Companion Animal PoC Blood Testing Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.5.5. Australia
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competitive Scenario
    • 8.5.5.3. Regulatory Framework
    • 8.5.5.4. Australia Companion Animal PoC Blood Testing Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.5.6. South Korea
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competitive Scenario
    • 8.5.6.3. Regulatory Framework
    • 8.5.6.4. South Korea Companion Animal PoC Blood Testing Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.5.7. Thailand
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Scenario
    • 8.5.7.3. Regulatory Framework
    • 8.5.7.4. Thailand Companion Animal PoC Blood Testing Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 8.6. Latin America
  • 8.6.1. Latin America Companion Animal PoC Blood Testing Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.6.2. Brazil
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. Brazil Companion Animal PoC Blood Testing Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.6.3. Argentina
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. Argentina Companion Animal PoC Blood Testing Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 8.7. Middle East & Africa
  • 8.7.1. Middle East & Africa Companion Animal PoC Blood Testing Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.7.2. South Africa
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Framework
    • 8.7.2.4. South Africa Companion Animal PoC Blood Testing Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.7.3. Saudi Arabia
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Framework
    • 8.7.3.4. Saudi Arabia Companion Animal PoC Blood Testing Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.7.4. UAE
    • 8.7.4.1. Key Country Dynamics
    • 8.7.4.2. Competitive Scenario
    • 8.7.4.3. Regulatory Framework
    • 8.7.4.4. UAE Companion Animal PoC Blood Testing Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.7.5. Kuwait
    • 8.7.5.1. Key Country Dynamics
    • 8.7.5.2. Competitive Scenario
    • 8.7.5.3. Regulatory Framework
    • 8.7.5.4. Kuwait Companion Animal PoC Blood Testing Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.7.6. Oman
    • 8.7.6.1. Key Country Dynamics
    • 8.7.6.2. Competitive Scenario
    • 8.7.6.3. Regulatory Framework
    • 8.7.6.4. Oman Companion Animal PoC Blood Testing Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.7.7. Qatar
    • 8.7.7.1. Key Country Dynamics
    • 8.7.7.2. Competitive Scenario
    • 8.7.7.3. Regulatory Framework
    • 8.7.7.4. Qatar Companion Animal PoC Blood Testing Market Estimates And Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
  • 9.1.1. Market Leaders
  • 9.1.2. Emerging Players
• 9.2. Company Market Position Analysis/ Heap Map Analysis, 2025
• 9.3. Company Profiles
  • 9.3.1. IDEXX Laboratories
    • 9.3.1.1. Participant's Overview
    • 9.3.1.2. Financial Performance
    • 9.3.1.3. Product Benchmarking
    • 9.3.1.4. Strategic Initiatives
  • 9.3.2. Zoetis
    • 9.3.2.1. Participant's Overview
    • 9.3.2.2. Financial Performance
    • 9.3.2.3. Product Benchmarking
    • 9.3.2.4. Strategic Initiatives
  • 9.3.3. Fujifilm Holdings Corporation
    • 9.3.3.1. Participant's Overview
    • 9.3.3.2. Financial Performance
    • 9.3.3.3. Product Benchmarking
    • 9.3.3.4. Strategic Initiatives
  • 9.3.4. Virbac
    • 9.3.4.1. Participant's Overview
    • 9.3.4.2. Financial Performance
    • 9.3.4.3. Product Benchmarking
    • 9.3.4.4. Strategic Initiatives
  • 9.3.5. Thermo Fisher Scientific
    • 9.3.5.1. Participant's Overview
    • 9.3.5.2. Financial Performance
    • 9.3.5.3. Product Benchmarking
    • 9.3.5.4. Strategic Initiatives
  • 9.3.6. BIONOTE
    • 9.3.6.1. Participant's Overview
    • 9.3.6.2. Financial Performance
    • 9.3.6.3. Product Benchmarking
    • 9.3.6.4. Strategic Initiatives
  • 9.3.7. Mars, Incorporated
    • 9.3.7.1. Participant's Overview
    • 9.3.7.2. Financial Performance
    • 9.3.7.3. Product Benchmarking
    • 9.3.7.4. Strategic Initiatives
  • 9.3.8. Randox Laboratories Ltd.
    • 9.3.8.1. Participant's Overview
    • 9.3.8.2. Financial Performance
    • 9.3.8.3. Product Benchmarking
    • 9.3.8.4. Strategic Initiatives
  • 9.3.9. ProtectLife International Biomedical Inc.
    • 9.3.9.1. Participant's Overview
    • 9.3.9.2. Financial Performance
    • 9.3.9.3. Product Benchmarking
    • 9.3.9.4. Strategic Initiatives
  • 9.3.10. Chengdu Seamaty Technology Co., Ltd.
    • 9.3.10.1. Participant's Overview
    • 9.3.10.2. Financial Performance
    • 9.3.10.3. Product Benchmarking
    • 9.3.10.4. Strategic Initiatives